Filter Results


Study status

(for at least one location)



Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1-6 of 6 for

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. A Study to Assess the Efficacy and Safety of Ruxolitinib Cream in Children With Atopic Dermatitis (TRuE-AD3)

    Rochester, MN

  2. IL-4 and Insulin Resistance for Treatment of Patients with Atopic Dermatitis

    Scottsdale/Phoenix, AZ

  3. Determining Molecular Drivers of Radiation Dermatitis

    Jacksonville, FL

  4. Study to Analyze the Metabolic Environment in Preventing Atopic Dermatitis

    Rochester, MN

  5. A Study to Evaluate Radiation Dermatitis Severity in Irradiated Skin protected By An Agent Versus Uncovered Skin

    Rochester, MN

  6. A Study of Patients Undergoing Therapy for Immune-Mediated Inflammatory Skin Conditions (IMISC)

    Rochester, MN


Mayo Clinic Footer